These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 25238263)

  • 21. Clinical Significance of Circulating CD33+CD11b+HLA-DR- Myeloid Cells in Patients with Stage IV Melanoma Treated with Ipilimumab.
    Sade-Feldman M; Kanterman J; Klieger Y; Ish-Shalom E; Olga M; Saragovi A; Shtainberg H; Lotem M; Baniyash M
    Clin Cancer Res; 2016 Dec; 22(23):5661-5672. PubMed ID: 27178742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.
    Karakasheva TA; Waldron TJ; Eruslanov E; Kim SB; Lee JS; O'Brien S; Hicks PD; Basu D; Singhal S; Malavasi F; Rustgi AK
    Cancer Res; 2015 Oct; 75(19):4074-85. PubMed ID: 26294209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus.
    Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD
    Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples.
    Kotsakis A; Harasymczuk M; Schilling B; Georgoulias V; Argiris A; Whiteside TL
    J Immunol Methods; 2012 Jul; 381(1-2):14-22. PubMed ID: 22522114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells are associated with poor prognosis in patients with small-cell lung cancer.
    Tian T; Gu X; Zhang B; Liu Y; Yuan C; Shao L; Guo Y; Fan K
    Cancer Biomark; 2015; 15(4):425-32. PubMed ID: 25792471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-induced CD14+HLA-DR (-/low) myeloid-derived suppressor cells correlate with tumor progression and outcome of therapy in multiple myeloma patients.
    Wang Z; Zhang L; Wang H; Xiong S; Li Y; Tao Q; Xiao W; Qin H; Wang Y; Zhai Z
    Cancer Immunol Immunother; 2015 Mar; 64(3):389-99. PubMed ID: 25548095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myeloid-derived suppressor cells are associated with disease progression and decreased overall survival in advanced-stage melanoma patients.
    Jordan KR; Amaria RN; Ramirez O; Callihan EB; Gao D; Borakove M; Manthey E; Borges VF; McCarter MD
    Cancer Immunol Immunother; 2013 Nov; 62(11):1711-22. PubMed ID: 24072401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood CD33(+)HLA-DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer.
    Verschoor CP; Johnstone J; Millar J; Dorrington MG; Habibagahi M; Lelic A; Loeb M; Bramson JL; Bowdish DM
    J Leukoc Biol; 2013 Apr; 93(4):633-7. PubMed ID: 23341539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of myeloid-derived suppressor cells in patients with acute coronary syndrome.
    Wang YG; Xiong X; Chen ZY; Liu KL; Yang JH; Wen Q; Wu FQ; Hu XF; Peng YD; Wu JJ; Lian YT; Zhang WC; Cheng LX
    Cell Physiol Biochem; 2015; 35(1):292-304. PubMed ID: 25591771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expansion of monocytic myeloid-derived suppressor cells in endometriosis patients: A pilot study.
    Chen H; Qin S; Lei A; Li X; Gao Q; Dong J; Xiao Q; Zhou J
    Int Immunopharmacol; 2017 Jun; 47():150-158. PubMed ID: 28407569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Nutritional Status in the Treatment Outcome for Esophageal Squamous Cell Carcinoma.
    Chen MF; Hsieh CC; Chen PT; Lu MS
    Nutrients; 2021 Aug; 13(9):. PubMed ID: 34578883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck.
    Chen WC; Lai CH; Chuang HC; Lin PY; Chen MF
    Head Neck; 2017 Feb; 39(2):347-355. PubMed ID: 27696591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD14
    Bernsmeier C; Triantafyllou E; Brenig R; Lebosse FJ; Singanayagam A; Patel VC; Pop OT; Khamri W; Nathwani R; Tidswell R; Weston CJ; Adams DH; Thursz MR; Wendon JA; Antoniades CG
    Gut; 2018 Jun; 67(6):1155-1167. PubMed ID: 28592438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [
    Xu HJ; Qi YJ; Wu DR; Liu QW; Chen P; Li MX; Jiao YL; Ruan HJ; Li ZT; Gao SG
    Zhonghua Zhong Liu Za Zhi; 2024 Aug; 46(8):746-754. PubMed ID: 39143797
    [No Abstract]   [Full Text] [Related]  

  • 36. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment.
    Bianchi G; Vuerich M; Pellegatti P; Marimpietri D; Emionite L; Marigo I; Bronte V; Di Virgilio F; Pistoia V; Raffaghello L
    Cell Death Dis; 2014 Mar; 5(3):e1135. PubMed ID: 24651438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3.
    Trovato R; Fiore A; Sartori S; Canè S; Giugno R; Cascione L; Paiella S; Salvia R; De Sanctis F; Poffe O; Anselmi C; Hofer F; Sartoris S; Piro G; Carbone C; Corbo V; Lawlor R; Solito S; Pinton L; Mandruzzato S; Bassi C; Scarpa A; Bronte V; Ugel S
    J Immunother Cancer; 2019 Sep; 7(1):255. PubMed ID: 31533831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The expression and association of CD14(+) HLA-DR(Low/-) myeloid-derived suppressor cell-like cells and interleukin-1β in ovarian cancer].
    Wang HY; Zhao R; Ren H; Zou MJ; Zhang J; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2663-2669. PubMed ID: 28910953
    [No Abstract]   [Full Text] [Related]  

  • 39. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
    Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
    Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased frequencies of CD11b(+) CD33(+) CD14(+) HLA-DR(low) myeloid-derived suppressor cells are an early event in melanoma patients.
    Rudolph BM; Loquai C; Gerwe A; Bacher N; Steinbrink K; Grabbe S; Tuettenberg A
    Exp Dermatol; 2014 Mar; 23(3):202-4. PubMed ID: 24495013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.